Kopran Limited (NSE:KOPRAN)
India · Delayed Price · Currency is INR 265.21
+5.45 (2.10%)
Nov 11, 2026, 1:30 PM IST
Kopran Market Cap
Kopran has a market cap or net worth of 12.8 billion as of November 10, 2026. Its market cap has increased by 64.34% in one year.
Market Cap
12.80B
Enterprise Value
14.80B
Revenue
7.94B
Global Rank
n/a
Country Rank
n/a
PE Ratio
32.51
ChartMarket Cap Chart
Since April 1, 2002, Kopran's market cap has increased from 572.00M to 12.80B, an increase of 2,136.97%. That is a compound annual growth rate of 13.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 12.80B | 76.78% |
| Dec 31, 2025 | 7.24B | -29.34% |
| Dec 31, 2024 | 10.24B | -11.98% |
| Dec 29, 2023 | 11.64B | 60.08% |
| Dec 30, 2022 | 7.27B | -48.06% |
| Dec 31, 2021 | 14.00B | 132.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Rubicon Research | 293.27B |
| Pfizer | 179.24B |
| CORONA Remedies | 155.31B |
| Marksans Pharma | 139.91B |
| Sanofi Consumer Healthcare India | 79.44B |
| Senores Pharmaceuticals | 54.11B |
| SMS Pharmaceuticals | 48.06B |
| Sai Parenteral's | 22.36B |